BNCT clinical trials
Phase II clinical trials
The start dates are shown below for two phase II trials using a 10B compound formulation developed by Stella Pharma and an accelerator-based BNCT system created by Sumitomo Heavy Industries.
| Phase II trial for recurrent malignant glioma | December 2015 |
| Phase II trial for head and neck cancer | June 2016 |
World’s first BNCT trials
Recurrent malignant glioma
▷Phase II clinical trial started in December 2015
Head and neck cancer
▷Phase II clinical trial started in June 2016
Drug approval process
